Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs): a Delphi study

Paediatric Rheumatology International Trials Organisation (PRINTO) and the AIDs Delphi study participants

Research output: Contribution to journalReview article

Abstract

Autoinflammatory diseases (AIDs) are a relatively new family of disorders, defined about 19 years ago. Some of them are hereditary and some are not. The names given to these diseases do not follow any systematic guidelines, and sometimes the same disorder carries several names. The aim of this study is to refine the definition of AIDs and to provide some conventions for their naming. We focused mainly on monogenetic AIDs. Delphi technique, which enables consensus among a group of experts through internet and mail communication and questionnaires, was employed. After achieving 100% consensus among six members of a steering committee, the questionnaire containing AID definitions and the agreed-upon conventions were sent to 26 physicians and researchers working in the field of AIDs in order to gain broader support for the committee's proposals. The committee proposed the following definition for AIDs: "Autoinflammatory diseases are clinical disorders caused by defect(s) or dysregulation of the innate immune system, characterized by recurrent or continuous inflammation (elevated acute phase reactants-APR) and the lack of a primary pathogenic role for the adaptive immune system (autoreactive T-cells or autoantibody production)." Several rules were defined for guiding the naming of these diseases among which are: abandoning eponyms and preferring the name of the gene over its encoded protein. The new definition for AIDs allows inclusion of clinical disorders mainly associated with defects in the innate immune system. The new conventions propose names with clinical meaning and in some cases even clues for treatment.

Original languageEnglish
Pages (from-to)1558-1565
Number of pages8
JournalAnnals of the Rheumatic Diseases
Volume77
Issue number11
DOIs
Publication statusPublished - Nov 2018

Fingerprint

Delphi Technique
Taxonomies
Consensus
Names
Immune system
Immune System
Eponyms
Acute-Phase Proteins
Defects
Cytomegalovirus Infections
Postal Service
T-cells
Internet
Autoantibodies
Communication
Research Personnel
Guidelines
Genes
Inflammation
Physicians

Cite this

Paediatric Rheumatology International Trials Organisation (PRINTO) and the AIDs Delphi study participants (2018). Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs): a Delphi study. Annals of the Rheumatic Diseases, 77(11), 1558-1565. https://doi.org/10.1136/annrheumdis-2017-212515

Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs) : a Delphi study. / Paediatric Rheumatology International Trials Organisation (PRINTO) and the AIDs Delphi study participants.

In: Annals of the Rheumatic Diseases, Vol. 77, No. 11, 11.2018, p. 1558-1565.

Research output: Contribution to journalReview article

Paediatric Rheumatology International Trials Organisation (PRINTO) and the AIDs Delphi study participants 2018, 'Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs): a Delphi study', Annals of the Rheumatic Diseases, vol. 77, no. 11, pp. 1558-1565. https://doi.org/10.1136/annrheumdis-2017-212515
Paediatric Rheumatology International Trials Organisation (PRINTO) and the AIDs Delphi study participants. Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs): a Delphi study. Annals of the Rheumatic Diseases. 2018 Nov;77(11):1558-1565. https://doi.org/10.1136/annrheumdis-2017-212515
Paediatric Rheumatology International Trials Organisation (PRINTO) and the AIDs Delphi study participants. / Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs) : a Delphi study. In: Annals of the Rheumatic Diseases. 2018 ; Vol. 77, No. 11. pp. 1558-1565.
@article{441ccc5aeda745b0a2d1e8a31bfd6670,
title = "Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs): a Delphi study",
abstract = "Autoinflammatory diseases (AIDs) are a relatively new family of disorders, defined about 19 years ago. Some of them are hereditary and some are not. The names given to these diseases do not follow any systematic guidelines, and sometimes the same disorder carries several names. The aim of this study is to refine the definition of AIDs and to provide some conventions for their naming. We focused mainly on monogenetic AIDs. Delphi technique, which enables consensus among a group of experts through internet and mail communication and questionnaires, was employed. After achieving 100{\%} consensus among six members of a steering committee, the questionnaire containing AID definitions and the agreed-upon conventions were sent to 26 physicians and researchers working in the field of AIDs in order to gain broader support for the committee's proposals. The committee proposed the following definition for AIDs: {"}Autoinflammatory diseases are clinical disorders caused by defect(s) or dysregulation of the innate immune system, characterized by recurrent or continuous inflammation (elevated acute phase reactants-APR) and the lack of a primary pathogenic role for the adaptive immune system (autoreactive T-cells or autoantibody production).{"} Several rules were defined for guiding the naming of these diseases among which are: abandoning eponyms and preferring the name of the gene over its encoded protein. The new definition for AIDs allows inclusion of clinical disorders mainly associated with defects in the innate immune system. The new conventions propose names with clinical meaning and in some cases even clues for treatment.",
author = "{Paediatric Rheumatology International Trials Organisation (PRINTO) and the AIDs Delphi study participants} and Eldad Ben-Chetrit and Marco Gattorno and Ahmet Gul and Kastner, {Daniel L} and Lachmann, {Helen J} and Isabelle Touitou and Nicolino Ruperto",
note = "{\circledC} Author(s) (or their employer(s)) 2018. No commercial re-use. See rights and permissions. Published by BMJ.",
year = "2018",
month = "11",
doi = "10.1136/annrheumdis-2017-212515",
language = "English",
volume = "77",
pages = "1558--1565",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group",
number = "11",

}

TY - JOUR

T1 - Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs)

T2 - a Delphi study

AU - Paediatric Rheumatology International Trials Organisation (PRINTO) and the AIDs Delphi study participants

AU - Ben-Chetrit, Eldad

AU - Gattorno, Marco

AU - Gul, Ahmet

AU - Kastner, Daniel L

AU - Lachmann, Helen J

AU - Touitou, Isabelle

AU - Ruperto, Nicolino

N1 - © Author(s) (or their employer(s)) 2018. No commercial re-use. See rights and permissions. Published by BMJ.

PY - 2018/11

Y1 - 2018/11

N2 - Autoinflammatory diseases (AIDs) are a relatively new family of disorders, defined about 19 years ago. Some of them are hereditary and some are not. The names given to these diseases do not follow any systematic guidelines, and sometimes the same disorder carries several names. The aim of this study is to refine the definition of AIDs and to provide some conventions for their naming. We focused mainly on monogenetic AIDs. Delphi technique, which enables consensus among a group of experts through internet and mail communication and questionnaires, was employed. After achieving 100% consensus among six members of a steering committee, the questionnaire containing AID definitions and the agreed-upon conventions were sent to 26 physicians and researchers working in the field of AIDs in order to gain broader support for the committee's proposals. The committee proposed the following definition for AIDs: "Autoinflammatory diseases are clinical disorders caused by defect(s) or dysregulation of the innate immune system, characterized by recurrent or continuous inflammation (elevated acute phase reactants-APR) and the lack of a primary pathogenic role for the adaptive immune system (autoreactive T-cells or autoantibody production)." Several rules were defined for guiding the naming of these diseases among which are: abandoning eponyms and preferring the name of the gene over its encoded protein. The new definition for AIDs allows inclusion of clinical disorders mainly associated with defects in the innate immune system. The new conventions propose names with clinical meaning and in some cases even clues for treatment.

AB - Autoinflammatory diseases (AIDs) are a relatively new family of disorders, defined about 19 years ago. Some of them are hereditary and some are not. The names given to these diseases do not follow any systematic guidelines, and sometimes the same disorder carries several names. The aim of this study is to refine the definition of AIDs and to provide some conventions for their naming. We focused mainly on monogenetic AIDs. Delphi technique, which enables consensus among a group of experts through internet and mail communication and questionnaires, was employed. After achieving 100% consensus among six members of a steering committee, the questionnaire containing AID definitions and the agreed-upon conventions were sent to 26 physicians and researchers working in the field of AIDs in order to gain broader support for the committee's proposals. The committee proposed the following definition for AIDs: "Autoinflammatory diseases are clinical disorders caused by defect(s) or dysregulation of the innate immune system, characterized by recurrent or continuous inflammation (elevated acute phase reactants-APR) and the lack of a primary pathogenic role for the adaptive immune system (autoreactive T-cells or autoantibody production)." Several rules were defined for guiding the naming of these diseases among which are: abandoning eponyms and preferring the name of the gene over its encoded protein. The new definition for AIDs allows inclusion of clinical disorders mainly associated with defects in the innate immune system. The new conventions propose names with clinical meaning and in some cases even clues for treatment.

U2 - 10.1136/annrheumdis-2017-212515

DO - 10.1136/annrheumdis-2017-212515

M3 - Review article

C2 - 30100561

VL - 77

SP - 1558

EP - 1565

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 11

ER -